Artificial Intelligence (AI) is a concept of using machines to perform problem-solving functions previously reliant on human intervention. Machine learning, a subset of AI, is the ability of applications to improve performance over time as they consume data. Healthcare is an industry that is utilizing AI for drug discovery. AbbVie and AbCellera Biologics are two companies that are using AI to develop drugs and discover antibodies. AbbVie has a strong portfolio of drugs in development and a 4% dividend, while AbCellera Biologics is a smaller company with a $2 billion market cap that may be attractive to investors with high risk tolerance.
